Viewing Study NCT01949467

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:44 AM
Ignite Modification Date: 2026-02-01 @ 12:40 PM
Study NCT ID: NCT01949467
Status: COMPLETED
Last Update Posted: 2019-03-27
First Post: 2013-09-20
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Analysis of the Modulation of Serum Hepcidin Level in Response to Iron Oral Intake: Potential Interest for the Differential Diagnosis Between Ferroportin Disease and Dysmetabolic Hepatosiderosis.
Sponsor: Rennes University Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hemochromatosis, Type 4 View
None Ferroportin Disease View
None Dysmetabolic Hepatosiderosis View
None Diagnosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ferroportin disease View
None dysmetabolic hepatosiderosis View
None genetic hemochromatosis View
None hyperferritinemia View
None hepcidin View
None iron fumarate View
None physiopathological study View
None diagnosis View
None HFE gene View
None TRF2 gene View
None iron parameters View
None divalent cations View